1,3-β-D-glucan testing for nocardiosis in solid organ transplant recipients

Zachary A Yetmar; Douglas W Challener; Maria Teresa Seville; Wendelyn Bosch; Elitza S Theel; Elena Beam

doi:10.1111/tid.13991

1,3-β-D-glucan testing for nocardiosis in solid organ transplant recipients

Transpl Infect Dis. 2022 Dec;24(6):e13991. doi: 10.1111/tid.13991. Epub 2022 Nov 15.

Authors

Zachary A Yetmar¹, Douglas W Challener¹, Maria Teresa Seville², Wendelyn Bosch³, Elitza S Theel⁴, Elena Beam¹

Affiliations

¹ Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Phoenix, Arizona, USA.
³ Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
⁴ Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Abstract

From 23 SOTRs with nocardiosis, 2 had positive 1,3-β-D-glucan tests and both had alternative reasons for positive tests. 1,3-β-D-glucan does not appear to be useful for diagnosis of nocardiosis.

Keywords: 1,3-β-D-glucan; diagnostic testing; fungitell; nocardiosis; organ transplantation.

Publication types

Letter

MeSH terms

Glucans
Humans
Nocardia Infections* / diagnosis
Nocardia Infections* / drug therapy
Nocardia*
Organ Transplantation* / adverse effects
Transplant Recipients

Substances

Glucans

Abstract

Publication types

MeSH terms

Substances

Grants and funding